These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20686302)

  • 1. A case of McArdle disease: efficacy of vitamin B6 on fatigability and impaired glycogenolysis.
    Izumi R; Suzuki N; Kato K; Warita H; Tateyama M; Nakashima I; Itoyama Y
    Intern Med; 2010; 49(15):1623-5. PubMed ID: 20686302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [McArdle's disease in a 14-year-old girl with fatigability and raised muscle enzymes].
    López-Pisón J; Muñoz-Albillos MS; Boudet-García A; Giménez-Más JA; Peña-Segura JL; Abenia-Usón P
    Rev Neurol; 2000 May 16-31; 30(10):932-4. PubMed ID: 10919189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency?
    Ørngreen MC; Schelhaas HJ; Jeppesen TD; Akman HO; Wevers RA; Andersen ST; ter Laak HJ; van Diggelen OP; DiMauro S; Vissing J
    Neurology; 2008 May; 70(20):1876-82. PubMed ID: 18401027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe axial myopathy in McArdle disease.
    Witting N; Duno M; Piraud M; Vissing J
    JAMA Neurol; 2014 Jan; 71(1):88-90. PubMed ID: 24216972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. McArdle disease in a patient with anorexia nervosa: a case report.
    Dalle Grave R; Patacca E; Conti M; Soave F; Dametti L; Dalle Grave A; Calugi S
    Eat Weight Disord; 2022 Dec; 27(8):3793-3796. PubMed ID: 35871462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. McArdle disease presenting as acute renal failure.
    Pillarisetti J; Ahmed A
    South Med J; 2007 Mar; 100(3):313-6. PubMed ID: 17396739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRES leading to the diagnosis of McArdle disease.
    Martinez-Thompson JM; Pittock SJ; Milone M
    J Clin Neurosci; 2017 Dec; 46():62-64. PubMed ID: 28887083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle phosphorylase kinase deficiency: a neutral metabolic variant or a disease?
    Preisler N; Orngreen MC; Echaniz-Laguna A; Laforet P; Lonsdorfer-Wolf E; Doutreleau S; Geny B; Akman HO; Dimauro S; Vissing J
    Neurology; 2012 Jan; 78(4):265-8. PubMed ID: 22238410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [McArdle disease (gycogenosis type V): analysis of clinical, biological and genetic features of five French patients].
    Delmont E; Sacconi S; Berge-Lefranc JL; Aquaron R; Butori C; Desnuelle C
    Rev Neurol (Paris); 2008 Nov; 164(11):912-6. PubMed ID: 18808785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and nutritional treatment trials in McArdle disease.
    Quinlivan RM; Beynon RJ
    Acta Myol; 2007 Jul; 26(1):58-60. PubMed ID: 17915572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease.
    Vissing J; Duno M; Schwartz M; Haller RG
    Brain; 2009 Jun; 132(Pt 6):1545-52. PubMed ID: 19433441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired glycogen breakdown and synthesis in phosphoglucomutase 1 deficiency.
    Preisler N; Cohen J; Vissing CR; Madsen KL; Heinicke K; Sharp LJ; Phillips L; Romain N; Park SY; Newby M; Wyrick P; Mancias P; Galbo H; Vissing J; Haller RG
    Mol Genet Metab; 2017 Nov; 122(3):117-121. PubMed ID: 28882528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercising with blocked muscle glycogenolysis: Adaptation in the McArdle mouse.
    Nielsen TL; Pinós T; Brull A; Vissing J; Krag TO
    Mol Genet Metab; 2018 Jan; 123(1):21-27. PubMed ID: 29174367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatigue and associated factors in 172 patients with McArdle disease: An international web-based survey.
    Slipsager A; Andersen LK; Voermans NC; Lucia A; Karazi W; Santalla A; Vissing J; Løkken N
    Neuromuscul Disord; 2024 Jan; 34():19-26. PubMed ID: 38042739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Late diagnosis of a McArdle disease's case (type V glycogenosis)].
    Flavier S; Rolland MO; Eude M; Fédou C; Brun JF; Maire I; Mercier J; Raynaud E
    Ann Biol Clin (Paris); 2007; 65(5):550-4. PubMed ID: 17913675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium valproate increases the brain isoform of glycogen phosphorylase: looking for a compensation mechanism in McArdle disease using a mouse primary skeletal-muscle culture in vitro.
    de Luna N; Brull A; Guiu JM; Lucia A; Martin MA; Arenas J; Martí R; Andreu AL; Pinós T
    Dis Model Mech; 2015 May; 8(5):467-72. PubMed ID: 25762569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent acute kidney failure due to McArdle disease.
    Noshad H; Sadreddini S; Ghaffari AR
    Iran J Kidney Dis; 2008 Oct; 2(4):234-6. PubMed ID: 19377243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial.
    Vorgerd M; Grehl T; Jager M; Muller K; Freitag G; Patzold T; Bruns N; Fabian K; Tegenthoff M; Mortier W; Luttmann A; Zange J; Malin JP
    Arch Neurol; 2000 Jul; 57(7):956-63. PubMed ID: 10891977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of changes in fat availability on exercise capacity in McArdle disease.
    Andersen ST; Jeppesen TD; Taivassalo T; Sveen ML; Heinicke K; Haller RG; Vissing J
    Arch Neurol; 2009 Jun; 66(6):762-6. PubMed ID: 19506137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PYGM expression analysis in white blood cells: a complementary tool for diagnosing McArdle disease?
    de Luna N; Brull A; Lucia A; Santalla A; Garatachea N; Martí R; Andreu AL; Pinós T
    Neuromuscul Disord; 2014 Dec; 24(12):1079-86. PubMed ID: 25240406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.